LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article ; Online: Anisocoria and optic neuritis associated with Mycoplasma pneumoniae infection.

    Gayoso-Cantero, Diego / Sarró-Fuentes, Claudia / Barón-Rubio, Manuel / Losa-García, Juan Emilio

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2023  Volume 41, Issue 5, Page(s) 312–314

    MeSH term(s) Humans ; Pneumonia, Mycoplasma/complications ; Anisocoria/complications ; Optic Neuritis/etiology ; Optic Neuritis/complications
    Language English
    Publishing date 2023-01-14
    Publishing country Spain
    Document type Case Reports ; Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2023.01.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Intestinal spirochetosis in a Spanish hospital.

    Chichón Sánchez, Marta / López Brasal, Laura / Losa García, Juan Emilio

    Medicina clinica

    2020  Volume 156, Issue 10, Page(s) 521–522

    Title translation Espiroquetosis intestinal en un hospital terciario de Madrid.
    MeSH term(s) Colon ; Hospitals ; Humans ; Intestinal Mucosa ; Spirochaetales Infections/diagnosis ; Spirochaetales Infections/epidemiology
    Language Spanish
    Publishing date 2020-07-02
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2020.04.047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Integration of beta-lactam allergy evaluation in a Spanish antibiotic stewardship programme.

    Moreno-Nuñez, Leonor / Rosado-Ingelmo, Ana / González-Moreno, Ana / Martín-Segarra, Oriol / Hervás-Gómez, Rafael / Sanz-Márquez, Sira / Pérez-Fernández, Elia / Losa-García, Juan-Emilio / Tejedor-Alonso, Miguel-Angel

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

    2023  Volume 53, Issue 12, Page(s) 1314–1317

    MeSH term(s) Humans ; beta-Lactams/adverse effects ; Antimicrobial Stewardship ; Hypersensitivity ; Anti-Bacterial Agents/adverse effects ; Drug Hypersensitivity/diagnosis ; Penicillins
    Chemical Substances beta-Lactams ; Anti-Bacterial Agents ; Penicillins
    Language English
    Publishing date 2023-09-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 645204-8
    ISSN 1365-2222 ; 0954-7894 ; 0960-2178
    ISSN (online) 1365-2222
    ISSN 0954-7894 ; 0960-2178
    DOI 10.1111/cea.14388
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Impact of Penicillin Allergy Label on Length of Stay and Mortality in Hospitalized Patients through a Clinical Administrative National Dataset.

    Pérez-Encinas, Montserrat / Lorenzo-Martínez, Susana / Losa-García, Juan Emilio / Walter, Stefan / Tejedor-Alonso, Miguel Angel

    International archives of allergy and immunology

    2021  Volume 183, Issue 5, Page(s) 498–506

    Abstract: Background: Penicillin allergy is a common problem in the management of infectious diseases. The aim of this study was to determine the impact of penicillin allergy on length of hospital stay (LOHS) among hospitalized adult patients and on in-hospital ... ...

    Abstract Background: Penicillin allergy is a common problem in the management of infectious diseases. The aim of this study was to determine the impact of penicillin allergy on length of hospital stay (LOHS) among hospitalized adult patients and on in-hospital mortality at a national level.
    Methods: A retrospective cohort study of adult patients discharged from the Spanish Hospital System between 2006 and 2015 was conducted using the Minimum Basic Data Set (MBDS). We compared LOHS and in-hospital mortality of adult patients whose records contained penicillin allergy code V14.0 (International Classification of Diseases, Ninth Revision, Clinical Modification) as a secondary diagnosis, with a random sample without such a code.
    Results: We identified 981,291 admissions with code V14.0, which corresponded to 2.63% of all hospitalizations. Adults patients with a penicillin allergy label were significantly older than patients without such a label, with a median of 70 years (interquartile range [IQR]: 51-80) versus 63 years (IQR: 40-77). The proportion of women and the prevalence of infectious diseases were higher in the group with a penicillin allergy label (61.40% vs. 53.84%; 34.04% vs. 30.01%; respectively). We found a higher median Elixhauser-Van Walraven score in hospitalized patients with an allergy label. The median LOHS for hospitalizations with a penicillin allergy label (5 [IQR: 2-9]) was significantly longer than that in those without such a label (4 [IQR: 2-9]). Multivariate analysis showed an increase in LOHS due to the penicillin allergy label (odds ratio [OR] [95% confidence interval [CI]: 1.061 [1.057-1.065]) and a decrease in mortality in penicillin allergy records (OR [95% CI]: 0.834 [0.825-0.844]).
    Conclusion: In our study, the prevalence of a penicillin allergy label in hospitalized patients, using the MBDS, is low. Hospitalizations with an allergy label was associated with a longer LOHS. However, penicillin-allergic patients did not show higher mortality rates. Inaccurate reporting of penicillin allergies may have an impact on healthcare resources.
    MeSH term(s) Adult ; Anti-Bacterial Agents/therapeutic use ; Delivery of Health Care ; Drug Hypersensitivity/drug therapy ; Female ; Humans ; Length of Stay ; Penicillins/adverse effects ; Retrospective Studies
    Chemical Substances Anti-Bacterial Agents ; Penicillins
    Language English
    Publishing date 2021-12-17
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1108932-5
    ISSN 1423-0097 ; 1018-2438
    ISSN (online) 1423-0097
    ISSN 1018-2438
    DOI 10.1159/000520644
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Asymptomatic portal vein thrombosis associated to acute cytomegalovirus infection in an immunocompetent patient.

    Mendoza Lizardo, Sandra Scarleth / Losa García, Juan Emilio / Moreno Nuñez, Leonor

    Medicina clinica

    2017  Volume 150, Issue 2, Page(s) 82–83

    Title translation Trombosis portal asintomática asociada a infección aguda por citomegalovirus en paciente inmunocompetente.
    MeSH term(s) Acute Disease ; Adult ; Asymptomatic Diseases ; Cytomegalovirus Infections/complications ; Cytomegalovirus Infections/diagnosis ; Cytomegalovirus Infections/immunology ; Female ; Humans ; Immunocompetence ; Portal Vein ; Venous Thrombosis/diagnosis ; Venous Thrombosis/immunology ; Venous Thrombosis/virology
    Language Spanish
    Publishing date 2017-09-14
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2017.07.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Antibiotic discontinuation through an antibiotic treatment optimization program in emergency department patients with low suspicion of infection.

    Martínez-de la Cruz, Paula / Moreno-Núñez, Leonor / Álvarez-Atienza, Sara / Sanz-Márquez, Sira / Valverde-Canovas, José Francisco / Losa-García, Juan Emilio

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2022  Volume 41, Issue 7, Page(s) 423–425

    Abstract: Introduction: One of the most important strategies of PROA in the Emergency Department (ED) is the accurate diagnosis of infection to avoid inappropriate prescription. Our objective is to evaluate patients who receive antibiotics despite not having ... ...

    Abstract Introduction: One of the most important strategies of PROA in the Emergency Department (ED) is the accurate diagnosis of infection to avoid inappropriate prescription. Our objective is to evaluate patients who receive antibiotics despite not having objective data of infection.
    Methods: We carried out a cross-sectional study of patients admitted to the ED of the Hospital Universitario Fundación Alcorcón in which it was recommended to suspend the antibiotic through the PROA. Clinical and epidemiological characteristics and 30-day follow-up were analyzed to assess readmissions and mortality.
    Results: 145 patients were analyzed. It was recommended to suspend the antibiotic in 25. 44% of them had a diagnosis of urinary infection. The suspension recommendation was accepted by 88%. No patient died and one was readmitted.
    Conclusions: An important percentage of patients are prescribed antibiotics despite not having infection criteria, the clinical evolution after suspension of antibiotics was favorable.
    Language English
    Publishing date 2022-11-06
    Publishing country Spain
    Document type Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2022.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sexually transmitted infections in a cohort of HIV-positive patients.

    Nuno-Gonzalez, Almudena / López Estebaranz, José Luis / Losa Garcia, Juan Emilio

    Medicina clinica

    2016  Volume 148, Issue 7, Page(s) 329–330

    Title translation Infecciones de transmisión sexual en una cohorte de pacientes VIH positivos.
    MeSH term(s) Female ; HIV Infections/complications ; HIV Infections/epidemiology ; HIV Infections/transmission ; Humans ; Male ; Retrospective Studies ; Spain/epidemiology
    Language Spanish
    Publishing date 2016-12-28
    Publishing country Spain
    Document type Letter
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2016.11.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Experience in the use of dalbavancin in diabetic foot infection.

    Navarro-Jiménez, Gema / Fuentes-Santos, Cristina / Moreno-Núñez, Leonor / Alfayate-García, Jesús / Campelo-Gutierrez, Carolina / Sanz-Márquez, Sira / Pérez-Fernández, Elia / Velasco-Arribas, María / Hervás-Gómez, Rafael / Martín-Segarra, Oriol / Losa-García, Juan Emilio

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2022  Volume 40, Issue 6, Page(s) 296–301

    Abstract: Objective: To describe the clinical experience with dalbavancin in the treatment of diabetic foot infection in a multidisciplinary unit of a second level hospital.: Methods: A retrospective, descriptive study was made with all patients with diabetic ... ...

    Abstract Objective: To describe the clinical experience with dalbavancin in the treatment of diabetic foot infection in a multidisciplinary unit of a second level hospital.
    Methods: A retrospective, descriptive study was made with all patients with diabetic foot infection treated with dalbavancin in the Diabetic Foot Unit of Hospital Universitario Fundación Alcorcón, covering the period from September 2016 to December 2019. Demographic parameters and comorbidities, characteristics of the infection and treatment with dalbavancin were recorded. The cure rate is estimated at 90 days after finishing the treatment.
    Results: A total of 23 patients with diabetic foot infection (osteomyelitis) started treatment with dalbavancin, 19 were men and the mean age was 65 years. The microorganisms most frequently isolated for the indication of treatment with dalbavancin were Staphylococcus aureus (11) and Corynebacterium striatum (7). Dalbavancin was used as a second choice therapy in 22 cases, in 11 due to toxicity from other antibiotics. The median duration of treatment was 5 (4-7) weeks; the most frequent dose of dalbavancin (8 patients) was 1000 mg followed by 500 mg weekly for 5 weeks. 3 patients presented mild side effects (nausea and gastrointestinal discomfort). At 90 days after completion of dalbavancin therapy, 87% (20) of the patients were cured (95% CI: 65.2%-94.52%).
    Conclusion: Patients with osteomyelitis due to gram-positive microorganisms who received as part of the multidisciplinary antibiotic treatment with dalbavancin, had a high rate of cure with adequate tolerance and few side effects. Dalbavancin offers a safe alternative in treating deep diabetic foot infection.
    MeSH term(s) Aged ; Anti-Bacterial Agents ; Communicable Diseases ; Diabetes Mellitus/chemically induced ; Diabetes Mellitus/drug therapy ; Diabetic Foot/chemically induced ; Diabetic Foot/complications ; Diabetic Foot/drug therapy ; Female ; Humans ; Male ; Osteomyelitis/drug therapy ; Osteomyelitis/microbiology ; Retrospective Studies ; Teicoplanin/analogs & derivatives
    Chemical Substances Anti-Bacterial Agents ; Teicoplanin (61036-62-2) ; dalbavancin (808UI9MS5K)
    Language English
    Publishing date 2022-04-27
    Publishing country Spain
    Document type Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2022.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Human papilloma virus dermatosis in human immunodeficiency virus-positive patients: A 14-year retrospective study in 965 patients.

    Nuno-Gonzalez, Almudena / Losa Garcia, Juan Emilio / López Estebaranz, José Luis / Martin-Rios, María Dolores

    Medicina clinica

    2017  Volume 148, Issue 9, Page(s) 401–404

    Abstract: Introduction: The incidence of the human papilloma virus (HPV) has not dropped in HIV-positive patients despite the discovery of antiretroviral therapy (ART). Our goal is to assess the prevalence of HPV in HIV patients and its relationship with the ... ...

    Title translation Dermatosis por virus de papiloma humano (VPH) en pacientes infectados por el virus de la inmunodeficiencia humana (VIH): estudio retrospectivo de 965 pacientes durante 14 años.
    Abstract Introduction: The incidence of the human papilloma virus (HPV) has not dropped in HIV-positive patients despite the discovery of antiretroviral therapy (ART). Our goal is to assess the prevalence of HPV in HIV patients and its relationship with the epidemiological and virological characteristics of HIV patients.
    Patients and methods: Retrospective cohort of 965 patients diagnosed with HIV from 1998 to 2012. We analyzed patients' demographic factors and factors related to the HPV.
    Results: Of the 965 patients examined, 333 consulted a dermatologist. Of these, 52 patients had genital warts (15.6%), 43 had common warts (12.9%) and 8% had both conditions. In total, 28.5% of patients had a skin lesion caused by HPV.
    Discussion and conclusion: This is the first longitudinal observational study carried out on HIV-positive patients in the era of ART in which HPV infection is the most common skin pathology. We observed a similar trend in countries with access to ART. This study spreads awareness on the importance of preventing HPV and the difficulty of treating it in HIV-positive patients.
    Language Spanish
    Publishing date 2017-05-10
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2016.12.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Experience in the use of dalbavancin in diabetic foot infection.

    Navarro-Jiménez, Gema / Fuentes-Santos, Cristina / Moreno-Núñez, Leonor / Alfayate-García, Jesús / Campelo-Gutierrez, Carolina / Sanz-Márquez, Sira / Pérez-Fernández, Elia / Velasco-Arribas, María / Hervás-Gómez, Rafael / Martín-Segarra, Oriol / Losa-García, Juan Emilio

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2021  

    Abstract: Objective: To describe the clinical experience with dalbavancin in the treatment of diabetic foot infection in a multidisciplinary unit of a second level hospital.: Methods: A retrospective, descriptive study was made with all patients with diabetic ... ...

    Title translation Experiencia con el uso de dalbavancina en la infección profunda de pie diabético.
    Abstract Objective: To describe the clinical experience with dalbavancin in the treatment of diabetic foot infection in a multidisciplinary unit of a second level hospital.
    Methods: A retrospective, descriptive study was made with all patients with diabetic foot infection treated with dalbavancin in the Diabetic Foot Unit of Hospital Universitario Fundación Alcorcón, covering the period from September 2016 to December 2019. Demographic parameters and comorbidities, characteristics of the infection and treatment with dalbavancin were recorded. The cure rate was estimated at 90 days after finishing the treatment.
    Results: A total of 23 patients with diabetic foot infection (osteomyelitis) started treatment with dalbavancin, 19 were men and the mean age was 65 years. The microorganisms most frequently isolated for the indication of treatment with dalbavancin were Staphylococcus aureus (11) and Corynebacterium striatum (7). Dalbavancin was used as a second choice therapy in 22 cases, in 11 due to toxicity from other antibiotics. The median duration of treatment was 5 (4-7) weeks; the most frequent dose of dalbavancin (8 patients) was 1000mg followed by 500mg weekly for 5 weeks. 3 patients presented mild side effects (nausea and gastrointestinal discomfort). At 90 days after completion of dalbavancin therapy, 87% (20) of the patients were cured (95% CI: 65.2%-94.52%).
    Conclusion: Patients with osteomyelitis due to gram-positive microorganisms who received as part of the multidisciplinary antibiotic treatment with dalbavancin, had a high rate of cure with adequate tolerance and few side effects. Dalbavancin offers a safe alternative in treating deep diabetic foot infection.
    Language Spanish
    Publishing date 2021-01-12
    Publishing country Spain
    Document type Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimc.2020.11.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top